Cargando…
Irisin levels in LMNA-mutated lipodystrophic syndromes
Autores principales: | Bensmaine, Faiza, Vantyghem, Marie-Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652528/ http://dx.doi.org/10.1186/1750-1172-10-S2-O21 |
Ejemplares similares
-
Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
por: Vigouroux, Corinne, et al.
Publicado: (2018) -
Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019) -
Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015) -
SUN-037 Diagnosis Challenge in Type 4 Familial Partial Lipodystrophic Syndrome
por: Vantyghem, Marie-Christine, et al.
Publicado: (2019) -
Management of congenital muscular dystrophies related to defects in the LMNA gene
por: Quijano-Roy, Susana, et al.
Publicado: (2015)